Antibiotic-resistant enterococci and the changing face of surgical infections

Archives of Surgery

Volumn 131, Issue 3, 1996, Pages 338-342

  De Vera, Michael E ^a   Simmons, Richard L ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; LINCOSAMIDE DERIVATIVE; MACROLIDE; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; ENTEROCOCCUS; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; PRIORITY JOURNAL; SURGICAL INFECTION;

EID: 0029921159     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430150116021     Document Type: Article

References (59)

1. Kaye D Enterococci, biologic and epidemiologic characteristics and in vitro susceptibility. Arch Intern Med 1982;142:2006-2009.
2. Schleifer KH, Kilpper-Balz R Transfer of Streptococcus faecalis and Streptococcus faecium to the genus Enterococcus nom. rev as Enterococcus faecalis comb. nov and Enterococcus faecium comb. nov. Int J Syst Bacteriol 1984;34:31-34.
3. Collins MD, Jones D, Farrow JAE, Kilpper-Balz R, Schleifer KH. Enterococcus avium nom. rev., comb. nov., E casseliflavus nom. rev., comb. nov ; E durans nom. rev., comb. nov.; E gallinarum comb nov., and E malodoratus sp. nov. Int J Syst Bacteriol 1984,34:220-223.
4. Moellering RC Jr. Emergence of enterococcus as a significant pathogen. Clin Infect Dis. 1992;14:1173-1178
5. Banerjee SN, Emori TG, Culver DH, et al Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System Am J Med. 1991;3(suppl B):86-89.
6. Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988,67:248-269.
7. Moellering RC Jr The Enterococcus a classic example of the impact of antimicrobial resistance on therapeutic options J Antimicrob Chemother 1991; 28.1-12
8. Fontana R, Amalfitano G Rossi L, Satta G. Mechanisms of resistance to growth inhibition and killing by β-lactam antibiotics in enterococci. Clin Infect Dis 1992;15 486-489.
9. Murray BE, Mederski-Samoraj B Transferable β-lactamase a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest. 1983; 72 1168-1171.
10. Murray BE β-Lactamase producing enterococci. Antimicrob Agents Chemother. 1992,36:2355-2359.
11. Neu HC. Emergence and mechanisms of bacterial resistance in surgical infections. Am J Surg 1995,169(suppl 5A).13-20.
12. Murray BE The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3:46-65
13. Bush LM, Calmon J, Cherney CL, et al High-level penicillin resistance among isolates of enterococci: implications for treatment of enterococcal infections. Ann Intern Med. 1989;110:515-520.
14. Mederski-Samoraj BD, Murray BE. High-level resistance to gentamicin in clinical isolates of enterococci. J Infect Dis. 1983;147:751-757.
15. Zimmerman RA, Moellering RC Jr, Weinberg AN Mechanism of resistance to antibiotic synergism in enterococci. J Bacteriol. 1971,105:873-879.
16. Standiford HD, deMaine JB, Kirby WM. Antibiotic synergism of enterococci: relation to inhibitory concentrations Arch Intern Med. 1970;126:255-259.
17. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet. 1988;1:57-58.
18. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319: 157-161.
19. Karanfil LV, Murphy M, Josephson A, et al A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992,13:195-200.
20. Frieden TR, Munsiff SS, Low DE, et al Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993,342:76-79.
21. Livomese LL Dias S, Samuel C, et al. Hospital-acquired infection with vancomycin-resistant Enteroccous faecium transmitted by electronic thermometers. Ann Intern Med. 1993;117.112-116.
22. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993; 42:597-599.
23. Shlaes DM Vancomycin-resistant bacteria. Infect Control Hosp Epidemiol. 1992; 13:193-194
24. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993;37:1563-1571.
25. Arthur M, Molinas C, Depardieu F, Courvalin P Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993;175:117-127.
26. Leclercq R, Derlot ED, Weber M, Duval J, Courvalin P. Transferable vancomycin and teicoplanin resistance in Enteroccccus faecium. Antimicrob Agents Chemother. 1989;33 10-15
27. Bentorcha F, De Cespedes G, Horaud T. Tetracycline resistance heterogeneity in Enterococcus faecium. Antimicrob Agents Chemother. 1991;35:808-812.
28. Pepper K, Le Bouguenec C, De Cespedes G, Horaud T. Dispersal of a plasmid-borne chloramphenicol resistance gene in streptococcal and enterococcal plasmids. Plasmid. 1986,16.195-203.
29. Courvalin P, Ounissi H, Arthur M Multiplicity of macrolide-lincosamide-streptogramin antibiotic resistance determinants J Antimicrob Chemother. 1985, 16(suppl A):91-100
30. Dougherty SH. Role of enterococcus in intra-abdominal sepsis. Am J Surg. 1984 148:308-312
31. Nichols RL, Muzik AC. Enterococcal infections in surgical patients the mystery continues Clin Infect Dis. 1992,15.72-76.
32. Horvitz RA, Von Graevenitz A. A clinical study of the role of enterococci as sole agents of wound and tissue infection. Yale J Biol Med. 1977;50:391-395.
33. Onderdonk AB, Bartlett JG, Louie T, Sullivan-Seigler N, Gorbach SL Microbial synergy in experimental intra-abdominal abscess. Infect Immun. 1976;13:22-26.
34. Willey SH, Hindes RG, Eliopoulos GM, Moellering RC Effects of clindamycin and gentamicin and other antimicrobial combinations against enterococci in an experimental model of intra-abdominal abscess. Surg Gynecol Obstet 1989; 169 199-202
35. Barie PS, Christou NV, Dellinger EP, et al. Pathogenicity of the Enterococcus in surgical infections. Ann Surg. 1989;212:155-159
36. Shlaes DM, Levy J, Wolinsky E. Enterococcal bacteremia without endocarditis. Arch Intern Med 1981;141:578-581.
37. Weinstein MP, Reller LB, Murphy JR, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults, I: laboratory and epidemiologic observations. Rev Infect Dis. 1983;5:35-53.
38. Bartlett JG. Intra-abdominal sepsis Med Clin North Am. 1995;79.599-617.
39. Garrison RN, Fry DE, Berberich S, Polk HC Jr. Enterococcal bacteremia: clinical implications and determinants of death. Ann Surg. 1982,196:43-47
40. Barrall DT, Kenney PR, Slotman GJ, Burchard KW. Enterococcal bacteremia in surgical patients. Arch Surg. 1985;120:57-63.
41. Hoge CW, Adams J, Buchanan B, Sears SD. Enterococcal bacteremia, to treat or not to treat, a reappraisal Rev Infect Dis. 1991;13.600-605.
42. Schaeberg DR, Culver CH, Gaynes RP Major trends in the microbial etiology of nosocomial infection Am J Med. 1991;91(suppl 3B):72-75
43. Dougherty SH, Flohr AB Simmons RL 'Breakthrough' enterococcal septicemia in surgical patients: nineteen cases and a review of the literature Arch Surg. 1983,118.232-238
44. Feliciano DV, Gentry LO, Bitondo CG, et al. Single agent cephalosporin prophylaxis for penetrating abdominal trauma: results and comment on the emergence of the Enterococcus. Am J Surg. 1986;152:674-681.
45. Yu VL. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Ann Intern Med. 1981;94:784-785.
46. Morris JG Jr, Shay DK, Hebden JN, et al Enterococci resistant to multiple antimicrobial agents, including vancomycin, establishment of endemicity in a university medical center Ann Intern Med. 1995;123:250-259.
47. Shay DK, Maloney SA, Moteclvo M. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections J Infect Dis 1995,172:993-100.
48. Montecalvo MA, Horowitz H Wormser GP, Seiter K, Carbonaro CA. Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 1995,39 794
49. Linden P, Pasculle AW, Riddler S, Kusne S, Silverman A, Dean J Quinupristin/ dalfopristin (RP59500) for the treatment of serious infection due to high level vancomycin-resistant Enterococcus faecium. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, October 7, 1994; Orlando, Fla
50. Linden P, Pasculle AW, Manez R, Silverman D, Kramer DJ, Kusne S. Utilization of novobiocin and ciprofloxacin for the treatment of serious infection dye to vancomycin resistant Enterococcus faecium (VREF) In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, October 18, 1993, New Orleans, La.
51. Sastry V, Brennan PJ, Levy MM, et al. Vancomycin-resistant enterococci an emerging problem in immunosuppressed transplant recipients. Transplant Proc. 1995;27:954-955.
52. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes in patients with bacteremia due to vancomycin-resistant and vancomycin-susceptible Enterococcus faecium. Clin Infect Dis. In press.
53. The Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance: recommendations of the HICPAC. Am J Infect Control. 1995;23:87-94.
54. Noble WC, Virani Z, Cree RG Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992;93:195-198.
55. Veach LA, Pfaller MA, Barrett M, Koontz FP, Wenzel RP. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol. 1990;28:2064-2068.
56. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med. 1991;115:674-680.
57. Burnett RJ, Haverstock DC, Dellinger EP, et al. Definition of the role of enterococcus in intra-abdominal infection: analysis of a prospective randomized trial. Surgery. 1995;118:716-723.
58. Tollemar J, Holmberg K, Ringden O, Lonnqvist B. Surveillance tests for the diagnosis of invasive fungal infections in bone marrow transplant recipients. Scand J Infect Dis. 1989;21:205-212
59. Pfaller M, Cabezudo I, Rogers TR. Predictive value of surveillance cultures for systemic infection due to Candida species. Eur J Clin Microbiol Infect Dis. 1987; 6:628-633.